Influence of comorbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: Results from a UK national register
Macfarlane GJ et al. Rheumatology (Oxford) 2018: key206. doi: 10.1093/rheumatology/key206
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.